Results 131 to 140 of about 2,392 (196)

GRPR-targeted Theranostics for Cancer Management: New approaches to maximize therapeutic success [PDF]

open access: yes
In nuclear medicine, molecular imaging utilizing tumor-targeting radioactive agents can be used to non-invasively identify cancer patients eligible for targeted radionuclide therapy based on a positive scan, a concept known as theranostics.
Verhoeven, Marjolein
core  

Pretargeted Immuno-PET Enables Monoclonal Antibody Imaging Beyond the Blood-Brain Barrier. [PDF]

open access: yesMol Pharm
Gustavsson T   +17 more
europepmc   +1 more source

GPA33-pretargeted radioimmunotherapy with mono- and bivalent DOTA-based Lu-177-labeled radiohaptens in a mouse orthotopic liver xenograft model of metastatic human colorectal cancer. [PDF]

open access: yesTheranostics
Le Roux AB   +13 more
europepmc   +1 more source

Pretargeting with Cucurbituril-Adamantane Host-Guest Pair in Xenograft Models. [PDF]

open access: yesJ Nucl Med, 2023
Jallinoja VIJ   +7 more
europepmc   +1 more source

Toward Realization of Bioorthogonal Chemistry in the Clinic. [PDF]

open access: yesTop Curr Chem (Cham)
de Roode KE, Rossin R, Robillard MS.
europepmc   +1 more source

Recent advances in multimodal imaging of infections: research highlights using Nuclear-Optical imaging. [PDF]

open access: yesEur J Nucl Med Mol Imaging
Welling MM   +4 more
europepmc   +1 more source

Click-to-Release for Controlled Immune Cell Activation: Tumor-Targeted Unmasking of an IL12 Prodrug. [PDF]

open access: yesPharmaceuticals (Basel)
den Brok MH   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy